Robert S. Mcdowell

Chief Scientific Officer

Robert McDowell has over three decades of experience discovering small molecule drugs in cardiovascular disease, inflammation and oncology, with seven compounds advancing into clinical trials. Dr. McDowell has been an integral part of MyoKardia since its inception in 2012, having served as Senior Vice President of Drug Discovery through October ...

Roles at MyoKardia

  • Chief Scientific Officer

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.